MS, S., T, C., PF, H., K, H., C, D., JS, J., & MM, P. (2021). Pretreatment Plasma IL-6 and YKL-40 and Overall Survival after Surgery for Metastatic Bone Disease of the Extremities. Cancers, 13(11), . https://doi.org/10.3390/cancers13112833
Chicago Style (17th ed.) CitationMS, Sørensen, Colding-Rasmussen T, Horstmann PF, Hindsø K, Dehlendorff C, Johansen JS, and Petersen MM. "Pretreatment Plasma IL-6 and YKL-40 and Overall Survival After Surgery for Metastatic Bone Disease of the Extremities." Cancers 13, no. 11 (2021). https://doi.org/10.3390/cancers13112833.
MLA (9th ed.) CitationMS, Sørensen, et al. "Pretreatment Plasma IL-6 and YKL-40 and Overall Survival After Surgery for Metastatic Bone Disease of the Extremities." Cancers, vol. 13, no. 11, 2021, https://doi.org/10.3390/cancers13112833.